QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 accelerate-diagnostics-q2-eps-050-beats-055-estimate-sales-299m-miss-301m-estimate

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate o...

 accelerate-diagnostics-announces-completion-of-its-wave-pre-clinical-trial-designed-to-deliver-rapid-antimicrobial-susceptibility-testing-directly-from-positive-blood-culture-bottles-and-bacterial-isolated-colonies-to-report-accurate-results-within-45-hours-on-average

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the successful...

 accelerate-diagnostics-q1-2024-gaap-eps-088-misses-072-estimate-sales-2921m-miss-3000m-estimate

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.88) per share which missed the analyst consensus estimate...

 craig-hallum-maintains-hold-on-accelerate-diagnostics-lowers-price-target-to-1

Craig-Hallum analyst Alexander Nowak maintains Accelerate Diagnostics (NASDAQ:AXDX) with a Hold and lowers the price target ...

 accelerate-diagnostics-q4-eps-089-misses-062-estimate-sales-303m-miss-345m-estimate

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.89) per share which missed the analyst consensus estimate...

 earnings-scheduled-for-march-28-2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

 why-transcode-therapeutics-shares-are-trading-lower-by-over-24-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,...

 why-accelerate-diagnostics-axdx-stock-is-down-38

Accelerate Diagnostics shares are trading lower by 38% during Friday's session. The company priced an underwritten public o...

 us-stocks-higher-schlumberger-earnings-beat-estimates

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday. Following the market o...

 accelerate-diagnostics-announces-pricing-of-15m-public-offering-and-private-placement-the-public-offering-price-for-each-unit-is-150-and-the-public-offering-price-for-each-pre-funded-unit-is-149

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) (the "Company") today announced the pricing of an underwritten public offeri...

 why-accelerate-diagnostics-axdx-stock-hit-a-new-52-week-low-today

Accelerate Diagnostics shares are trading lower by 23.2% Tuesday morning. The company announced the initiation of a proposed un...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION